FI944714A0 - New use of beta-carbolines - Google Patents
New use of beta-carbolinesInfo
- Publication number
- FI944714A0 FI944714A0 FI944714A FI944714A FI944714A0 FI 944714 A0 FI944714 A0 FI 944714A0 FI 944714 A FI944714 A FI 944714A FI 944714 A FI944714 A FI 944714A FI 944714 A0 FI944714 A0 FI 944714A0
- Authority
- FI
- Finland
- Prior art keywords
- carbolines
- beta
- new use
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4212529A DE4212529A1 (en) | 1992-04-10 | 1992-04-10 | Use of µ-carbolines as non-competitive glutamate antagonists |
PCT/EP1993/000858 WO1993020820A1 (en) | 1992-04-10 | 1993-04-06 | USE OF β-CARBOLINES |
Publications (2)
Publication Number | Publication Date |
---|---|
FI944714A0 true FI944714A0 (en) | 1994-10-07 |
FI944714A FI944714A (en) | 1994-10-07 |
Family
ID=6456829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI944714A FI944714A (en) | 1992-04-10 | 1994-10-07 | New use of beta-carbolines |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0633779A1 (en) |
JP (1) | JPH07505404A (en) |
KR (1) | KR950700739A (en) |
CA (1) | CA2117755A1 (en) |
DE (1) | DE4212529A1 (en) |
FI (1) | FI944714A (en) |
HU (1) | HUT68212A (en) |
IL (1) | IL105349A0 (en) |
WO (1) | WO1993020820A1 (en) |
ZA (1) | ZA932553B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4330175A1 (en) * | 1993-08-31 | 1995-03-02 | Schering Ag | Alkoxy substituted beta carbolines |
DE4436190A1 (en) * | 1994-10-10 | 1996-04-11 | Gerhard Prof Dr Bringmann | Halogenated β-carboline derivatives, process for their preparation and use of these substances for inhibiting the respiratory chain |
RU2106864C1 (en) | 1995-10-23 | 1998-03-20 | Николай Серафимович Зефиров | New approach to treatment of alzheimer's disease |
US6017903A (en) | 1996-09-27 | 2000-01-25 | Guilford Pharmaceuticals Inc. | Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors |
US5824662A (en) | 1996-09-27 | 1998-10-20 | Guilford Pharmaceuticals Inc. | Treatment of global and focal ischemia using naaladase inhibitors |
CN1230889A (en) | 1996-09-27 | 1999-10-06 | 吉尔福特药业有限公司 | Naaladase compositions and methods for treating glutamate abnormality and effecting neuronal activity in animals |
AU2006254897A1 (en) * | 2005-06-06 | 2006-12-14 | Fibrogen, Inc. | Improved treatment for anemia using a HIF-alpha stabilising agent |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3540653A1 (en) * | 1985-11-13 | 1987-05-14 | Schering Ag | NEW 3-OXADIAZOLE AND 3-CARBONIC ACID SS-CARBOLINE DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS |
DE3545776A1 (en) * | 1985-12-20 | 1987-06-25 | Schering Ag | 5-AMINOALKYL-SS-CARBOLINE DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS |
-
1992
- 1992-04-10 DE DE4212529A patent/DE4212529A1/en not_active Withdrawn
-
1993
- 1993-04-06 EP EP93908924A patent/EP0633779A1/en not_active Withdrawn
- 1993-04-06 CA CA002117755A patent/CA2117755A1/en not_active Abandoned
- 1993-04-06 JP JP5517954A patent/JPH07505404A/en active Pending
- 1993-04-06 HU HU9402925A patent/HUT68212A/en unknown
- 1993-04-06 WO PCT/EP1993/000858 patent/WO1993020820A1/en not_active Application Discontinuation
- 1993-04-08 ZA ZA932553A patent/ZA932553B/en unknown
- 1993-04-09 IL IL105349A patent/IL105349A0/en unknown
-
1994
- 1994-10-07 FI FI944714A patent/FI944714A/en not_active Application Discontinuation
- 1994-10-08 KR KR1019940703566A patent/KR950700739A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUT68212A (en) | 1995-06-28 |
IL105349A0 (en) | 1993-08-18 |
HU9402925D0 (en) | 1995-01-30 |
ZA932553B (en) | 1993-11-02 |
JPH07505404A (en) | 1995-06-15 |
CA2117755A1 (en) | 1993-10-11 |
DE4212529A1 (en) | 1993-10-14 |
WO1993020820A1 (en) | 1993-10-28 |
FI944714A (en) | 1994-10-07 |
EP0633779A1 (en) | 1995-01-18 |
KR950700739A (en) | 1995-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI944885A (en) | The basic part of the can | |
FI931408A0 (en) | ANORDINATION FOR FREESHING OF AMORPHIC STAOLREMSOR | |
NO973826D0 (en) | New use of mother-of-pearl preparations | |
NO930574L (en) | Procedure for the preparation of desfluran | |
SE458083B (en) | ELRADIATOR AND APPLICATION OF THE SAME | |
FI944714A (en) | New use of beta-carbolines | |
NO932860D0 (en) | PROCEDURE FOR PREPARATION OF CALCIUM-L-ASCORBATE-2-PHOSPHATE | |
NO940190D0 (en) | Use of x-ketoglutarate | |
NO944906L (en) | New use of benzo [gÅquoline derivatives | |
NO931399D0 (en) | USE OF NATURSTEIN | |
NO932783D0 (en) | PROCEDURE FOR THE PREPARATION OF IMIDAZOPYRIDINES | |
FI923360A (en) | PROCEDURE FOR FRAMSTATION OF DIMETHYLACETOACETAMIDE | |
NO944839D0 (en) | Use of bismuth | |
NO943793D0 (en) | New application of | |
KR930026760U (en) | Improved configuration of TVCR | |
NO954984D0 (en) | New application of Ambasilide | |
FI39U1 (en) | Anordning Foer flottning av naet under is | |
SE9001069D0 (en) | NEW USE OF RED-GREEN SYNGLAS | |
SE9203080D0 (en) | LINDRAGARE BEFORE USE UNDER IS | |
NO974941D0 (en) | New use of (S) -adenosyl-L-methionine (SAMe) | |
FI943855A0 (en) | Connection of components | |
NO174197C (en) | Use of natural gas | |
LV10073A (en) | Influence of Absinthis absolutizesan | |
SE8800420D0 (en) | LOCATION OF FOREMAL | |
FI1069U1 (en) | Construction of the structure |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |